CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer

被引：0
|
作者：
Asim Pervaiz
Michael Zepp
Saqib Mahmood
Doaa Mohamed Ali
Martin R. Berger
Hassan Adwan
机构：
[1] University of Health Sciences,Institute of Biomedical and Allied Health Sciences
[2] Toxicology and Chemotherapy Unit,undefined
[3] German Cancer Research Centre (DKFZ),undefined
[4] German University of Cairo,undefined
来源：
Cellular Oncology | 2019年 / 42卷
关键词：
Breast cancer; Bone metastasis; CCR5; Maraviroc; Cell cycle arrest; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 106
页数：13
相关论文
共 50 条
  • [31] Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis
    Asim Pervaiz
    Michael Zepp
    Rania Georges
    Frank Bergmann
    Saqib Mahmood
    Syeda Faiza
    Martin R. Berger
    Hassan Adwan
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 73 - 91
  • [32] Macrophage repolarization therapy in metastatic colorectal cancer: CCR5 inhibition
    Halama, Niels
    Zoernig, Inka
    Berthel, Anna
    Kahlert, Christoph
    Klupp, Fee
    Suarez-Carmona, Meggy
    Krauss, Juergen
    Brand, Karsten
    Lasitschka, Felix
    Lerchl, Tina
    Luckner-Minden, Claudia
    Ulrich, Alexis
    Weitz, Juergen
    Schneider, Martin
    Buechler, Markus W.
    Zitvogel, Laurence
    Herrmann, Thomas
    Benner, Axel
    Kunz, Christina
    Luecke, Stephan
    Springfeld, Christoph
    Falk, Christine
    Jaeger, Dirk
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [33] CCR5 antagonist, an ally to fight against metastatic colorectal cancer
    Mukaida, Naofumi
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S309 - S312
  • [34] Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases
    Zhao, Qihong
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (01) : 41 - 55
  • [35] CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
    Gonzalez-Martin, Alicia
    Mira, Emilia
    Manes, Santos
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 1045 - 1057
  • [36] Melatonin: A Potential Therapeutic Option for Breast Cancer
    Kong, Xiangyi
    Gao, Ran
    Wang, Zhongzhao
    Wang, Xiangyu
    Fang, Yi
    Gao, Jidong
    Reiter, Russel J.
    Wang, Jing
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020, 31 (11): : 859 - 871
  • [37] In vitro effects of the CCR5 inhibitor maraviroc on human T cell function
    Arberas, H.
    Guardo, A. C.
    Bargallo, M. E.
    Maleno, M. J.
    Calvo, M.
    Blanco, J. L.
    Garcia, F.
    Gatell, J. M.
    Plana, M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 577 - 586
  • [38] MARAVIROC, A CCR5 ANTAGONIST, PREVENTS DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN A MOUSE MODEL
    Ochoa-Callejero, L.
    Perez, L.
    Rubio, S.
    Oteo, J. A.
    Martinez, A.
    Blanco, J. R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S437 - S437
  • [39] Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
    Ochoa-Callejero, Laura
    Perez-Martinez, Laura
    Rubio-Mediavilla, Susana
    Oteo, Jose A.
    Martinez, Alfredo
    Blanco, Jose R.
    PLOS ONE, 2013, 8 (01):
  • [40] Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
    Latinovic, Olga
    Kuruppu, Janaki
    Davis, Charles
    Le, Nhut
    Heredia, Alonso
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1497 - 1510
12345